Applications, hearings, determinations, etc.: Mallinckrodt, Inc.,

[Federal Register: September 29, 2006 (Volume 71, Number 189)]

[Notices]

[Page 57570-57571]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr29se06-127]

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Registration

By Notice dated June 1, 2006, and published in the Federal Register on June 8, 2006, (71 FR 33315), Mallinckrodt Inc., 3600 North Second Street, St. Louis, Missouri 63147, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in Schedules I and II:

Drug

Schedule

Codeine-N-oxide (9053)..................... I Difenoxin (9168)........................... I Dihydromorphine (9145)..................... I Morphine-N-oxide (9307).................... I Norlevorphanol (9634)...................... I Normorphine (9313)......................... I Tetrahydrocannabinols (7370)............... I Alfentanil (9737).......................... II Amphetamine (1100)......................... II Ecgonine (9180)............................ II Codeine (9050)............................. II Dextropropoxyphene, bulk (9273)............ II Dihydrocodeine (9120)...................... II Diphenoxylate (9170)....................... II Diprenorphine (9058)....................... II Etorphine HCL (9059)....................... II Fentanyl (9801)............................ II Hydrocodone (9193)......................... II Hydromorphone (9150)....................... II Levo-alphacetylmethadol (9648)............. II Levorphanol (9220)......................... II Meperidine (9230).......................... II Methadone (9250)........................... II Methadone intermediate (9254).............. II Methamphetamine (1105)..................... II Methylphenidate (1724)..................... II Metopon (9260)............................. II Morphine (9300)............................ II Nabilone (7379)............................ II Noroxymorphone (9668)...................... II Opium extracts (9610)...................... II Opium fluid extract (9620)................. II Opium tincture (9630)...................... II Opium, granulated (9640)................... II Opium, powdered (9639)..................... II Oxycodone (9143)........................... II Oxymorphone (9652)......................... II Phenazocine (9715)......................... II Remifentanil (9739)........................ II Sufentanil (9740).......................... II Thebaine (9333)............................ II

The firm plans to manufacture the listed controlled substances for internal use and for sale to other companies.

Since the publication of the Notice of Application, it has been determined that drug code 7360 (Marihuana) is not needed as a bulk manufacturing drug code for the company. The company has subsequently withdrawn their request to add this code to their current application for registration.

[[Page 57571]]

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Mallinckrodt Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Mallinckrodt Inc. to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with State and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.

Dated: September 20, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6-16021 Filed 9-28-06; 8:45 am]

BILLING CODE 4410-09-P